Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of mRNA Vaccines and Therapeutics
1.2 Key Market Segments
1.2.1 mRNA Vaccines and Therapeutics Segment by Type
1.2.2 mRNA Vaccines and Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 mRNA Vaccines and Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global mRNA Vaccines and Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global mRNA Vaccines and Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 mRNA Vaccines and Therapeutics Market Competitive Landscape
3.1 Global mRNA Vaccines and Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global mRNA Vaccines and Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 mRNA Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global mRNA Vaccines and Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers mRNA Vaccines and Therapeutics Sales Sites, Area Served, Product Type
3.6 mRNA Vaccines and Therapeutics Market Competitive Situation and Trends
3.6.1 mRNA Vaccines and Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest mRNA Vaccines and Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 mRNA Vaccines and Therapeutics Industry Chain Analysis
4.1 mRNA Vaccines and Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of mRNA Vaccines and Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 mRNA Vaccines and Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Vaccines and Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global mRNA Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global mRNA Vaccines and Therapeutics Price by Type (2019-2024)
7 mRNA Vaccines and Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Vaccines and Therapeutics Market Sales by Application (2019-2024)
7.3 Global mRNA Vaccines and Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global mRNA Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
8 mRNA Vaccines and Therapeutics Market Segmentation by Region
8.1 Global mRNA Vaccines and Therapeutics Sales by Region
8.1.1 Global mRNA Vaccines and Therapeutics Sales by Region
8.1.2 Global mRNA Vaccines and Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America mRNA Vaccines and Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe mRNA Vaccines and Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific mRNA Vaccines and Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America mRNA Vaccines and Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa mRNA Vaccines and Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Moderna Therapeutics
9.1.1 Moderna Therapeutics mRNA Vaccines and Therapeutics Basic Information
9.1.2 Moderna Therapeutics mRNA Vaccines and Therapeutics Product Overview
9.1.3 Moderna Therapeutics mRNA Vaccines and Therapeutics Product Market Performance
9.1.4 Moderna Therapeutics Business Overview
9.1.5 Moderna Therapeutics mRNA Vaccines and Therapeutics SWOT Analysis
9.1.6 Moderna Therapeutics Recent Developments
9.2 CureVac
9.2.1 CureVac mRNA Vaccines and Therapeutics Basic Information
9.2.2 CureVac mRNA Vaccines and Therapeutics Product Overview
9.2.3 CureVac mRNA Vaccines and Therapeutics Product Market Performance
9.2.4 CureVac Business Overview
9.2.5 CureVac mRNA Vaccines and Therapeutics SWOT Analysis
9.2.6 CureVac Recent Developments
9.3 Translate Bio
9.3.1 Translate Bio mRNA Vaccines and Therapeutics Basic Information
9.3.2 Translate Bio mRNA Vaccines and Therapeutics Product Overview
9.3.3 Translate Bio mRNA Vaccines and Therapeutics Product Market Performance
9.3.4 Translate Bio mRNA Vaccines and Therapeutics SWOT Analysis
9.3.5 Translate Bio Business Overview
9.3.6 Translate Bio Recent Developments
9.4 BioNTech
9.4.1 BioNTech mRNA Vaccines and Therapeutics Basic Information
9.4.2 BioNTech mRNA Vaccines and Therapeutics Product Overview
9.4.3 BioNTech mRNA Vaccines and Therapeutics Product Market Performance
9.4.4 BioNTech Business Overview
9.4.5 BioNTech Recent Developments
9.5 Sangamo Therapeutics
9.5.1 Sangamo Therapeutics mRNA Vaccines and Therapeutics Basic Information
9.5.2 Sangamo Therapeutics mRNA Vaccines and Therapeutics Product Overview
9.5.3 Sangamo Therapeutics mRNA Vaccines and Therapeutics Product Market Performance
9.5.4 Sangamo Therapeutics Business Overview
9.5.5 Sangamo Therapeutics Recent Developments
9.6 Argos Therapeutics
9.6.1 Argos Therapeutics mRNA Vaccines and Therapeutics Basic Information
9.6.2 Argos Therapeutics mRNA Vaccines and Therapeutics Product Overview
9.6.3 Argos Therapeutics mRNA Vaccines and Therapeutics Product Market Performance
9.6.4 Argos Therapeutics Business Overview
9.6.5 Argos Therapeutics Recent Developments
9.7 In-Cell-Art
9.7.1 In-Cell-Art mRNA Vaccines and Therapeutics Basic Information
9.7.2 In-Cell-Art mRNA Vaccines and Therapeutics Product Overview
9.7.3 In-Cell-Art mRNA Vaccines and Therapeutics Product Market Performance
9.7.4 In-Cell-Art Business Overview
9.7.5 In-Cell-Art Recent Developments
9.8 eTheRNA
9.8.1 eTheRNA mRNA Vaccines and Therapeutics Basic Information
9.8.2 eTheRNA mRNA Vaccines and Therapeutics Product Overview
9.8.3 eTheRNA mRNA Vaccines and Therapeutics Product Market Performance
9.8.4 eTheRNA Business Overview
9.8.5 eTheRNA Recent Developments
9.9 Ethris
9.9.1 Ethris mRNA Vaccines and Therapeutics Basic Information
9.9.2 Ethris mRNA Vaccines and Therapeutics Product Overview
9.9.3 Ethris mRNA Vaccines and Therapeutics Product Market Performance
9.9.4 Ethris Business Overview
9.9.5 Ethris Recent Developments
9.10 Tiba Biotechnology
9.10.1 Tiba Biotechnology mRNA Vaccines and Therapeutics Basic Information
9.10.2 Tiba Biotechnology mRNA Vaccines and Therapeutics Product Overview
9.10.3 Tiba Biotechnology mRNA Vaccines and Therapeutics Product Market Performance
9.10.4 Tiba Biotechnology Business Overview
9.10.5 Tiba Biotechnology Recent Developments
10 mRNA Vaccines and Therapeutics Market Forecast by Region
10.1 Global mRNA Vaccines and Therapeutics Market Size Forecast
10.2 Global mRNA Vaccines and Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe mRNA Vaccines and Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific mRNA Vaccines and Therapeutics Market Size Forecast by Region
10.2.4 South America mRNA Vaccines and Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of mRNA Vaccines and Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global mRNA Vaccines and Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of mRNA Vaccines and Therapeutics by Type (2025-2030)
11.1.2 Global mRNA Vaccines and Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of mRNA Vaccines and Therapeutics by Type (2025-2030)
11.2 Global mRNA Vaccines and Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global mRNA Vaccines and Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global mRNA Vaccines and Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
